Hakmook Kang
Last active: 4/6/2017

Evaluating treatment response using DW-MRI and DCE-MRI in trastuzumab responsive and resistant HER2-overexpressing human breast cancer xenografts.

Whisenant JG, Sorace AG, McIntyre JO, Kang H, Sánchez V, Loveless ME, Yankeelov TE
Transl Oncol. 2014 7 (6): 768-79

PMID: 25500087 · PMCID: PMC4311041 · DOI:10.1016/j.tranon.2014.09.011

MeSH Terms (0)

Connections (2)

This publication is referenced by other Labnodes entities: